Chapter 34

  1. Aarestrup FM. 2001. Comparative ribotyping of Staphylococcus intermedius isolated from members of the Canoidea gives possible evidence for host-specificity and co-evolution of bacteria and hosts. Int J Syst Evol Microbiol 51:1343-1347.
  2. 1a. Abbott B, Leggett B, Rossney AS, et al. 2010. Isolation rates of meticillin-resistant staphylococcus aureus in dogs, cats and horses in Ireland. Vet Rec 166:451-455.
  3. Abraham J, Morris D, Griffeth G, et al. 2007. Surveillance of healthy cats and cats with inflammatory skin disease for colonization of the skin by methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi ssp. schleiferi. Vet Dermatol 18:252-259.
  4. Adamo PF, Cherubini GB. 2001. Discospondylitis associated with three unreported bacteria in the dog. J Small Anim Pract 42:352-355.
  5. Adesiyun AA, Usman B. 1983. Isolation of enterotoxigenic strains of staphylococci from dogs. Vet Microbiol 8:459-468.
  6. Alandejani T, Marsan J, Ferris W, et al. 2009. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Otolaryngology 141:114-118.
  7. Allaker RP, Garrett N, Kent L, et al. 1993. Characterisation of Staphylococcus intermedius isolates from canine pyoderma and from healthy carriers by SDS-PAGE of exoproteins, immunoblotting and restriction endonuclease digest analysis. J Med Microbiol 39:429-433.
  8. Allaker RP, Jensen L, Lloyd DH, et al. 1992. Colonization of neonatal puppies by staphylococci. Br Vet J 148:523-528.
  9. Allaker RP, Lloyd DH, Bailey RM. 1992. Population size and frequency of staphylococci at mucocutaneous sites on healthy dogs. Vet Rec 130:303-304.
  10. Allaker RP, Lloyd DH, Simpson AI. 1992. Occurrence of Staphylococcus intermedius on the hair and skin of normal dogs. Res Vet Sci 52:174-176.
  11. Anderson M, Weese J. 2007. Evaluation of a real-time polymerase chain reaction assay for rapid identification of methicillin-resistant Staphylococcus aureus directly from nasal swabs in horses. Vet Microbiol 122:185-189.
  12. Archer GL, Climo MW. 2005. Staphylococcus epidermidis and other coagulase negative staphylococci, pp 2352-2360. In Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases, ed 6. Elsevier, Philadelphia.
  13. Atalay B, Ergin F, Cekinmez M, et al. 2005. Brain abscess caused by Staphylococcus intermedius. Acta Neurochir 147:347-348.
  14. Badylak SF, Wu CC, Bible M, et al. 2003. Host protection against deliberate bacterial contamination of an extracellular matrix bioscaffold versus Dacron mesh in a dog model of orthopedic soft tissue repair. J Biomed Mater Res 67B:658-654.
  15. Bagcigil F, Moodley A, Baptiste K, et al. 2007. Occurrence, species distribution, antimicrobial resistance and clonality of methicillin- and erythromycin-resistant staphylococci in the nasal cavity of domestic animals. Vet Microbiol 121:307-315.
  16. Bakkali F, Averbeck S, Averbeck D, et al. 2008. Biological effects of essential oils—a review. Food Chem Toxicol 46:446-475.
  17. Baptiste K, Williams K, Willams N, et al. 2005. Methicillin-resistant staphylococci in companion animals. Emerg Infect Dis 11:1942-1944.
  18. Barrs VR, Briscoe D, Malik R, et al. 2000. Use of multilocus enzyme electrophoresis to distinguish clinically important strains of Staphylococcus intermedius from the skin of dogs. Aust Vet J 78:267-272.
  19. Barton M, Hawkes M, Moore D, et al. 2006. Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: a perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol 17(Suppl C):4C-24C.
  20. Basson NJ, Grobler SR. 2008. Antimicrobial activity of two South African honeys produced from indigenous Leucospermum cordifolium and Erica species on selected micro-organisms. BMC Complement Altern Med 8:41.
  21. 19a. Bearman GM, Rosato AE, Assanasen S, et al. 2010. Nasal carriage of inducible dormant and community-associated methicillin-resistant Staphylococcus aureus in an ambulatory population of predominantly university students. Int J Infect Dis 14:e18-e24.
  22. Becker K, Keller B, von Eiff C, et al. 2001. Enterotoxigenic potential of Staphylococcus intermedius. Appl Environ Microbiol 67:5551-5557.
  23. Bemis DA, Jones RD, Frank LA, et al. 2009. Evaluation of susceptibility test breakpoints used to predict mecA-mediated resistance in Staphylococcus pseudintermedius isolated from dogs. J Vet Diagn Invest 21:53-58.
  24. Bengtsson B. 2001. The first SVARM (Swedish Veterinary Antimicrobial Resistance Monitoring) report shows that the situation regarding resistance is good. Svensk-Veterinartidning 53:8-9, 455-457.
  25. 22a. Berube DE, Whelan MF, Tater KC, et al. Fournier's gangrene in a cat. J Vet Emerg Crit Care 20:148-154.
  26. Bes M, Guérin-Faublée V, Freney J, et al. 2002. Isolation of Staphylococcus schleiferi subspecies coagulans from two cases of canine pyoderma. Vet Rec 150:487-488.
  27. Bes M, Saidi Slim L, Becharnia F, et al 2002. Population diversity of Staphylococcus intermedius isolates from various host species: typing by 16S-23S intergenic ribosomal DNA spacer polymorphism analysis. J Clin Microbiol 40:2275-2277.
  28. Bjurstrom L, Linde-Forsberg C. 1992. Long-term study of aerobic bacteria of the genital tract of breeding bitches. Am J Vet Res 53:665-669.
  29. Blaser G, Santos K, Bode U, et al. 2007. Effect of medical honey on wounds colonised or infected with MRSA. J Wound Care 16:325-328.
  30. Bloom PB, Rosser EJ. 2001. Efficacy of once-daily clindamycin hydrochloride in the treatment of superficial bacterial pyoderma in dogs. J Am Anim Hosp Assoc 37:537-542.
  31. Boelens JJ, van der Poll T, Dankert J, et al. 2000. Interferon-γ protects against biomaterial-associated Staphylococcus epidermidis infections in mice. J Infect Dis 181:1167-1171.
  32. Boerlin P, Burnens AP, Frey J, et al. 2001. Molecular epidemiology and genetic linkage of macrolide and aminoglycoside resistance in Staphylococcus intermedius of canine origin. Vet Microbiol 79:155-169.
  33. Boerlin P, Eugster S, Gaschen F, et al. 2001. Transmission of opportunistic pathogens in a veterinary teaching hospital. Vet Microbiol 82:347-359.
  34. Boost M, O'donoghue M, Siu K. 2007. Characterisation of methicillin-resistant Staphylococcus aureus isolates from dogs and their owners. Clin Microbiol Infect 13:731-733.
  35. Bradon TD, Johnson CA, Wakeneil P, et al. 1988. Efficacy of clindamycin in the treatment of Staphylococcus aureus osteomyelitis in dogs. J Am Vet Med Assoc 192:1721-1725.
  36. Brady A, Loughlin R, Gilpin D, et al. 2006. In vitro activity of tea-tree oil against clinical skin isolates of methicillin-resistant and -sensitive Staphylococcus aureus and coagulase-negative staphylococci growing planktonically and as biofilms. J Med Microbiol 55:1375-1380.
  37. Bu P, Riske PS, Zaya NE, et al. 2007. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis. J Ocur Pharmacol Ther 23:213-220.
  38. Burkett G, Frank LA. 1998. Comparison of production of Staphylococcus intermedius exotoxin among clinically normal dogs, atopic dogs with recurrent pyoderma, and dogs with a single episode of pyoderma. J Am Vet Med Assoc 213:232-234.
  39. Burstiner L, Faires M, Weese JS. 2010. Methicillin-resistant Staphylococcus aureus colonization of veterinary personnel at a surgical conference. Vet Surg in press.
  40. Cabassu J, Moissonnier P. 2007. Surgical treatment of a vertebral fracture associated with a haematogenous osteomyelitis in a dog. Vet Comp Orthop Traumatol 20:227-230.
  41. Campanile F, Bongiorno D, Borbone S, et al. 2007. Characterization of a variant of the SCCmec element in a bloodstream isolate of Staphylococcus intermedius. Microb Drug Resist 13:7-10.
  42. 38a. Cardoso RL, Maboni F, Machado G, et al. 2010. Antimicrobial activity of propolis extract against Staphylococcus coagulase postitive and Malassezia pachydermatis of canine otitis. Vet Microbiol 142:432-434.
  43. Carlotti DN, Guaguere E, Pin D, et al. 1999. Therapy of difficult cases of canine pyoderma with marbofloxacin: a report of 39 dogs. J Small Anim Pract 40:265-270.
  44. Chang CY, Yang YL, Hsueh PR, et al. 2010. Catheter-related bacteremia caused by Staphylococcus pseudintermedius refractory to antibiotic-lock therapy in a haemophilic child with dog exposure. J Clin Microbiol 48:1497-1498.
  45. Chesney CJ. 1996. Mapping the canine skin: a study of coat relative humidity in Newfoundland dogs. Vet Dermatol 7:35-41.
  46. 41a. Chuang CY, Yang YL, PoRen H, et al. 2010. Catheter-related bacteremia caused by Staphylococcus pseudintermedius refractory to antibiotic-lock therapy in a hemophilic child with dog exposure. J Clin Microbiol 48:1497-1498.
  47. Clemetson LL, Ward AC. 1990. Bacterial flora of the vagina and uterus of healthy cats. J Am Vet Med Assoc 196:902-906.
  48. Cohn LA, Gary AT, Fales WH, et al. 2003. Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts. J Vet Diagn Invest 15:338-343.
  49. Colombini S, Merchant SR, Hosgood G. 2000. Microbial flora and antimicrobial susceptibility patterns from dogs with otitis media. Vet Dermatol 11:235-239.
  50. Cook LB, Bergman RL, Bahr A, et al. 2003. Inflammatory polyp in the middle ear with secondary suppurative meningoencephalitis in a cat. Vet Radiol Ultrasound 44:648-651.
  51. Cox HU. 1988. Unpublished observation. Louisiana State University, Baton Rouge.
  52. Cox HU. 1998. Staphylococcal infections, pp 214-217. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  53. Cox HU, Hoskins JD. 1990. Staphylococcal infection, pp 611-613. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  54. Cox HU, Hoskins JD, Newman SS, et al. 1988. Temporal study of staphylococcal species on healthy dogs. Am J Vet Res 49:747-751.
  55. Datta R, Huang SS. 2008. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 47:176-181.
  56. DeBoer DJ. 1994. Immunomodulatory effects of staphylococcal antigen and antigen-antibody complexes on canine mononuclear and polymorphonuclear leukocytes. Am J Vet Res 55:1690-1696.
  57. Del Beccaro MA. 1995. Melaleuca oil poisoning in a 17-month-old. Vet Hum Toxicol 37:557-558.
  58. Devriese LA, Hermans K, Baele M, et al. 2009. Staphylococcus pseudintermedius versus Staphylococcus intermedius. Vet Microbiol 133:206-207.
  59. Dewey CW. 2002. External hydrocephalus in a dog with suspected bacterial meningoencephalitis. J Am Anim Hosp Assoc 38:563-567.
  60. Dinges MM, Gregerson DS, Tripp TJ, et al. 2003. Effects of total body irradiation and cyclosporin A on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome. J Infect Dis 188:1142-1145.
  61. Dunman PM, Projan SJ. 2001. The regulation of virulence in the staphylococci, pp 1-16. In Honeyman AL, Friedman H (eds): Staphylococcus aureus infection and disease. Kluwer Academic, New York.
  62. Duquette RA, Nuttall TS. 2004. Methicillin-resistant Staphylococcus aureus in dogs and cats, an emerging problem. J Small Anim Pract 45:591-597.
  63. Edwards VM, Deringer JR, Callantine SD, et al. 1997. Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates. Infect Immun 65:2346-2352.
  64. Edwards-Jones V, Buck R, Shawcross SG, et al. 2004. The effect of essential oils on methicillin-resistant Staphylococcus aureus using a dressing model. Burns 30:772-777.
  65. Epstein CR, Yam WC, Peiris JS, et al. 2009. Methicillin-resistant commensal staphylococci in healthy dogs as a potential zoonotic reservoir for community-acquired antibiotic resistance. Infect Genet Evol 9:283-285.
  66. Ejiri N, Morimoto K, Tohma Y, et al. 1999. Infection of surgical wounds in dogs and cats with multi-resistant Staphylococcus aureus. J Jpn Vet Med Assoc 52:579-582.
  67. Faires M, Gard S, Slavic D, et al. 2009. Microbiological characterization of Staphylococcus pseudintermedius isolates from dogs. ASM-ESCMID conference on methicillin resistant staphylococci in animals, London, UK, Sept 22–25. A26.
  68. Faires MC, Gard S, Aucoin D, et al. 2009. Inducible clindamycin-resistance in methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius isolates from dogs and cats. Vet Microbiol 139:419-420.
  69. Faires MC, Traverse M, Tater KC, et al. 2010. Methicillin-resistant and susceptible Staphylococcus aureus infections in dogs. Emerg Infect Dis 16:69-75.
  70. Faires M, Weese JS. 2008. Prevalence of inducible clindamycin resistant Staphylococcus aureus isolates from dogs and cats, p 60. ASM Conference on Antimicrobial Resistance in Zoonotic and Foodborne Pathogens. Copenhagen, Denmark, June 15–18.
  71. Faires M, Weese JS. 2008. Risk factors for methicillin-resistant Staphylococcus aureus infection in small animals. ASM Conference on Antimicrobial Resistance in Zoonotic and Foodborne Pathogens. Copenhagen, Denmark, June 15–18.
  72. Faoagali J, George N, Leditschke JF. 1997. Does tea tree oil have a place in the topical treatment of burns? Burns 23:349-351.
  73. Farrar ET, Washabau RJ, Saunders HM. 1996. Hepatic abscesses in dogs: 14 cases (1982-1994). J Am Vet Med Assoc 208:243-247.
  74. Fazakerley J, Nuttall T, Sales D, et al. 2009. Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs. Vet Dermatol 20:179-184.
  75. 69a. Fazakerley J, Williams N, Carter S, et al. 2010. Heterogeneity of Staphylococcus pseudintermedius isolates from atopic and healthy dogs. Vet Derm 21:578-585.
  76. Fitch RB, Hogan TC, Kudnig ST. 2003. Hematogenous septic arthritis in the dog: results of five patients treated nonsurgically with antibiotics. J Am Anim Hosp Assoc 39:563-566.
  77. 70a. Floras A, Lawn K, Slavic D, et al. 2010. Sequence type 398 meticillin-resistant Staphylococcus aureus infection and colonization in dogs. Vet Rec 166:826-827.
  78. Forsythe PJ, Hill PB, Thoday KL, et al. 2002. Use of computerized image analysis to quantify staphylococcal adhesion to canine corneocytes: does breed and body site have any relevance to the pathogenesis of pyoderma? Vet Dermatol 13:29-36.
  79. Frank LA, Kania SA, Hnilica KA, et al. 2003. Isolation of Staphylococcus schleiferi from dogs with pyoderma. J Am Vet Med Assoc 222:451-454.
  80. Frank LA, Kania SA, Kirzeder EM. 2009. Risk of colonization or gene transfer to owners of dogs with methicillin-resistant Staphylococcus pseudintermedius. Vet Dermatol 20:496-501.
  81. Frazee B, Salz T, Lambert L, et al. 2005. Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia in an immunocompetent young adult. Ann Emerg Med 46:401-404.
  82. Futagawa-Saito K, Ba-Thein W, Sakurai N, et al. 2006. Prevalence of virulence factors in Staphylococcus intermedius isolates from dogs and pigeons. BMC Vet Res 2:4.
  83. Ganiere JP, Medaille C, Etore F. 2004. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolated from canine skin and ear infections. Res Vet Sci 77:67-71.
  84. Ganiere JP, Medaille C, Limet A, et al. 2001. Antimicrobial activity of enrofloxacin against Staphylococcus intermedius strains isolated from canine pyodermas. Vet Dermatol 12:171-175.
  85. Ganiere J, Medaille C, Mangion C. 2005. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma. J Vet Med B Infect Dis Vet Public Health 52:25-31.
  86. Geoghegan JA, Smith EJ, Speziale P, et al. 2009. Staphylococcus pseudintermedius expresses surface proteins that closely resemble those from Staphylococcus aureus. Vet Microbiol 138: 345-352.
  87. Gerding PA, McLaughlin SA, Troop MW. 1988. Pathogenic bacteria and fungi associated with external ocular diseases in dogs: 131 cases (1981-1986). J Am Vet Med Assoc 193:242-244.
  88. Gerstadt K, Daly JS, Mitchell M, et al. 1999. Methicillin-resistant Staphylococcus intermedius pneumonia following coronary artery bypass grafting. Clin Infect Dis 29:218-219.
  89. Gethin G, Cowman S. 2008. Bacteriological changes in sloughy venous leg ulcers treated with manuka honey or hydrogel: an RCT. J Wound Care 17:241-244, 246-247.
  90. Girard C, Higgins R. 1999. Staphylococcus intermedius cellulitis and toxic shock in a dog. Can Vet J 40:501-502.
  91. Gortel K, Campbell KL, Kakoma I, et al. 1999. Methicillin resistance among staphylococci isolated from dogs. Am J Vet Res 60:1526-1530.
  92. Gorwitz RJ, Jernigan D, Powers J, et al. 2006. Strategies for clinical management of MRSA in the community: summary of an experts’ meeting convened by the Centers for Disease Control and Prevention. Available at www.cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA_ExpMtgStrategies.pdf. Accessed 12/26/10.
  93. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. 2008. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 197:1226-1234.
  94. Gorz M, Rohde J, Amtsberg G. 1999. Prevalence and antibiotic resistance of bacterial pathogens isolated from dogs. Kleintierpraxis 44:77-90.
  95. Greene RT, Lammler C. 1993. Staphylococcus intermedius: current knowledge on a pathogen of veterinary importance. Zentralbl Veterinarmed B 40:206-214.
  96. Greene RT, Schwarz S. 1992. Small antibiotic resistance plasmids in Staphylococcus intermedius. Int J Med Microbiol Virol Parasitol Infect Dis 276:380-389.
  97. Griffeth GC, Morris DO, Abraham JL, et al. 2008. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin. Vet Dermatol 19:142-149.
  98. Gronlund-Andersson U, Finn M, Kadlec K, et al. 2009. Methicillin-resistant Staphylococcus pseudintermedius; an emerging companion animal health problem, p 89. ASM-ESCMID conference on methicillin-resistant staphylococci in animals, London, Sept 22-25. A-40.
  99. Guardabassi L, Houser GA, Frank LA, et al. 2008. Guidelines for antimicrobial use in dogs and cats, pp 183-306. In Guardabassi L, Jensen LB, Kruse H (eds): Guide to antimicrobial use in animals. Blackwell Publishing, Ames, IA.
  100. Guardabassi L, Loeber ME, Jacobson A. 2004. Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners. Vet Microbiol 98:23-27.
  101. Hada T, Furuse S, Matsumoto Y, et al. 2001. Comparison of the effects in vitro of tea tree oil and plaunotol on methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus. Microbios 106(Suppl 2):133-141.
  102. Hanselman B, Kruth S, Rousseau J, et al. 2006. Methicillin-resistant Staphylococcus aureus colonization in veterinary personnel. Emerg Infect Dis 12:1933-1938.
  103. Hanselman BA, Kruth SA, Rousseau J, et al. 2008. Methicillin-resistant Staphylococcus aureus colonization in schoolteachers in Ontario. Can J Infect Dis Med Microbiol 19:405-408.
  104. Hanselman BA, Kruth SA, Rousseau J, et al. 2009. Coagulase positive staphylococcal colonization of people and their household pets. Can Vet J 50: 954-958.
  105. Hanselman BA, Kruth S, Weese JS. 2007. Methicillin-resistant staphylococcal colonization in dogs entering a veterinary teaching hospital. Vet Microbiol 126:277-281.
  106. Hartmann FA, White DG, West SE, et al. 2005. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma. Vet Microbiol 108:119-131.
  107. Harvey RG, Lloyd DH. 1994. The distribution of Staphylococcus intermedius and coagulase-negative staphylococci on the hair, skin surface, within the hair follicles and on the mucous membranes of dogs. Vet Dermatol 5:75-81.
  108. Harvey RG, Noble WC, Ferguson EA. 1993. A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs. Vet Rec 132:351-353.
  109. 101a. Heller J, Kelly L, Reid SWJ, et al. 2010. Qualitative risk assessment of the acquisition of meticillin-resistant Staphylococcus aureus in pet dogs. Risk Analysis 30:458-472.
  110. Hendricks A, Schuberth HJ, Schueler K, et al. 2002. Frequency of superantigen-producing Staphylococcus intermedius isolates from canine pyoderma and proliferation-inducing potential of superantigens in dogs. Res Vet Sci 73:273-277.
  111. Hermans K, Devriese LA, Haesebrouck F. 2004. Staphylococcus, pp 43-56. In Gyles C, Prescott J, Songer G (eds): Pathogenesis of bacterial infections in animals, ed 3. Blackwell, Ames, IA.
  112. Herrmann M. 2003. Salicylic acid: an old dog, new tricks, and staphylococcal disease. J Clin Invest 112:149-151.
  113. Hess RS, Ilan I. 2003. Renal abscess in a dog with transient diabetes mellitus. J Small Anim Pract 44:13-16.
  114. Hesselbarth J, Schwarz S. 1995. Comparative ribotyping of Staphylococcus intermedius from dogs, pigeons, horses, and mink. Vet Microbiol 45:11-17.
  115. Hesselbarth J, Witte W, Cuny C, et al. 1994. Characterization of Staphylococcus intermedius from healthy dogs and cases of superficial pyoderma by DNA restriction endonuclease patterns. Vet Microbiol 41:259-266.
  116. Hirooka EY, Muller EE, Freitas JC, et al. 1988. Enterotoxigenicity of Staphylococcus intermedius of canine origin. Int J Food Microbiol 7:185-191.
  117. Hoekstra KA, Paulton RJ. 1996. Antibiotic sensitivity of Staphylococcus aureus and Staphylococcus intermedius of canine and feline origin. Lett Appl Microbiol 22:192-194.
  118. Hoekstra KA, Paulton RJL. 2002. Clinical prevalence and antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus intermedius in dogs. J Appl Microbiol 93:406-413.
  119. Hoie S, Fossum K. 1989. Antibodies to staphylococcal DNase in sera from different animal species, including humans. J Clin Microbiol 27:2444-2447.
  120. Holm BR, Petersson U, Mürner A, et al. 2002. Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden. Vet Rec 151:600-605.
  121. Holm BR, Rest JR, Seewald W. 2004. A prospective study of the clinical findings, treatment and histopathology of 44 cases of pyotraumatic dermatitis. Vet Dermatol 15:369-376.
  122. Horspool LJ, van Laar P, van den Bos R, et al. 2004. Treatment of canine pyoderma with ibafloxacin and marbofloxacin—fluoroquinolones with different pharmacokinetic profiles, J Vet Pharmacol Ther 27:147-153.
  123. Igimi S, Atobe H, Tohya Y, et al. 1994. Characterization of the most frequently encountered Staphylococcus species in cats. Vet Microbiol 39:255-260.
  124. Igimi S, Takahashi E, Mitsuoka T. 1990. Staphylococcus schleiferi subsp coagulans subsp nov., isolated from the external auditory meatus of dogs with external ear otitis. Int J Syst Bacteriol 40:409-411.
  125. 116a. Ishihara K, Shimokubo N, Sakagami A, et al. 2010. Occurrence and molecular charactereistics of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius in an academic veterinary hospital. App Environ Microbiol 76:5165-5174.
  126. 116b. Iyori K, Hisatsune J, Kawakami T, et al. 2010. Identification of a novel Staphylococcus pseudintermedius exfoliative toxin gene and its prevalence in isolates from canines with pyoderma and healthy dogs. FEMS Microbiol Lett 312:169-175.
  127. Jones R, Kania S, Rohrbach B, et al. 2007. Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1772 samples (2001-2005). J Am Vet Med Assoc 230:221-227.
  128. Jones T, Kellum M, Porter S, et al. 2002. An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 8:82-84.
  129. 118a. Kadelec K, Schwarz S, Perreten V, et al. 2010. Molecular analysis of methicillin-resistant Staphylococcus pseudintermedius of feline origin from different European countries and North America. J Antimicrob Chemother 65:1826-1837.
  130. Kania SA, Williamson NL, Frank LA, et al. 2004. Methicillin-resistance of staphylococci isolated from the skin of dogs with pyoderma. Am J Vet Res 65:1265-1268.
  131. Kazakova S, Hageman J, Matava M, et al. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352:468-475.
  132. Kempker R, Mangalat D, Kongphet-Tran T, et al. 2009. Beware of the pet dog: a case of Staphylococcus intermedius infection. Am J Med Sci 338:425-427.
  133. Kikuchi K, Karasawa T, Piao C, et al. 2004. Molecular confirmation of transmission route of Staphylococcus intermedius in mastoid cavity infection from dog saliva. J Infect Chemother 10:46-48.
  134. Kottler S, Middleton JR, Perry J, et al. 2010. Prevalence of Staphylococcus aureus and MRSA carriage in three populations. J Vet Intern Med 24:132-139.
  135. Kruse H, Hofshagen M, Thoresen SI, et al. 1996. The antimicrobial susceptibility of staphylococcal species isolated from canine dermatitis. Vet Res Commun 20:205-214.
  136. Kupferwasser LI, Yeaman MR, Nast CC, et al. 2003. Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 112:222-233.
  137. Kwakman PH, Van den Akker JP, Güçlü A, et al. 2008. Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization. Clin Infect Dis 46:1677-1682.
  138. Lautz S, Kanbar T, Alber J, et al. 2006. Dissemination of the gene encoding exfoliative toxin of Staphylococcus intermedius among strains isolated from dogs during routine microbiological diagnostics. J Vet Med B Infect Dis Vet Public Health 53:434-438.
  139. Lautzenhiser SJ, Fialkowski JP, Bjorling D, et al. 2001. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs. Res Vet Sci 70:239-241.
  140. Lee J. 1994. Staphylococcus intermedius isolated from dog-bite wounds. J Infect 29:105.
  141. Lefebvre SL, Reid-Smith RJ, Waltner-Toews D, et al. 2009. Incidence of acquisition of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and other health-care-associated pathogens by dogs that participate in animal-assisted interventions. J Am Vet Med Assoc 234:1404-1417.
  142. Leonard F, Abbott Y, Rossney A, et al. 2006. Methicillin-resistant Staphylococcus aureus isolated from a veterinary surgeon and five dogs in one practice. Vet Rec 158:155-159.
  143. Lilenbaum W, Esteves AL, Souza GN. 1999. Prevalence and antimicrobial susceptibility of staphylococci isolated from saliva of clinically normal cats. Lett Appl Microbiol 28:448-452.
  144. Lilenbaum W, Nunes EL, Azeredo MA. 1998. Prevalence and antimicrobial susceptibility of staphylococci isolated from the skin surface of clinically normal cats. Lett Appl Microbiol 27:224-228.
  145. Lina G, Bohach GA, Nair SP, et al. 2004. Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis 189:2334-2336.
  146. Litster A, Moss SM, Honnery M, et al. 2007. Prevalence of bacterial species in cats with clinical signs of lower urinary tract disease: recognition of Staphylococcus felis as a possible feline urinary tract pathogen. Vet Microbiol 121:182-188.
  147. Lloyd DH, Lamport AI, Feeney C. 1996. Sensitivity to antibiotics amongst cutaneous and mucosal isolates of canine pathogenic staphylococci in the UK 1980-1996. Vet Dermatol 7:171-175.
  148. Lloyd DH, Lamport AI, Noble WC, et al. 1999. Fluoroquinolone resistance in Staphylococcus intermedius. Vet Dermatol 10:249-251.
  149. Loeffler A, Baines SJ, Toleman MS, et al. 2008. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets. J Antimicrob Chemother 62:1301-1304.
  150. Loeffler A, Boag A, Sung J, et al. 2005. Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK. J Antimicrob Chemother 56:692-697.
  151. 139a. Loeffler A, Lloyd DH. 2010. Companion animals: a reservoir for methicillin-resistant Staphylococcus aureus in the community? Epidemiol Infect 138:595-605.
  152. Loeffler A, Pfeiffer DU, Lindsay JA, et al. 2010. Lack of transmission of methicillin-resistant Staphylococcus aureus (MRSA) between apparently healthy dogs in a rescue kennel. Vet Microbiol 141:178-181.
  153. Lyskova P, Vydrzalova M, Mazurova J. 2007. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa. J Vet Med A 54:559-563.
  154. Maeda Y, Loughrey A, Earle JA, et al. 2008. Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Complement Ther Clin Pract 14:77-82
  155. Mahoudeau I, Delabranche X, Prevost G, et al. 1997. Frequency of isolation of Staphylococcus intermedius from humans. J Clin Microbiol 35:2153-2154.
  156. 143a. Malayeri HZ, Jamshidi S, Salehi TZ. 2010. Identification and antimicrobial susceptibility patterns of bacteria causing otitis externa in dogs. Vet Res Commun 34:435-444.
  157. Malik S, Coombs G, O’Brien F, et al. 2006. Molecular typing of methicillin-resistant staphylococci isolated from cats and dogs. J Antimicrob Chemother 58:428-431.
  158. Manian FA. 2003. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis 36:26-28.
  159. Mason IS, Lloyd DH. 1995. The macroscopic and microscopic effects of intradermal injection of crude and purified staphylococcal extracts on canine skin. Vet Dermatol 6:197-204.
  160. Mason IS, Mason KV, Lloyd DH. 1996. A review of the biology of canine skin with respect to the commensals Staphylococcus intermedius, Demodex canis and Malassezia pachydermatis. Vet Dermatol 7:119-132.
  161. May ER, Hnilica KA, Frank LA, et al. 2005. Isolation of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma, or both. J Am Vet Med Assoc 227:928-931.
  162. McEwan NA. 2000. Adherence by Staphylococcus intermedius to canine keratinocytes in atopic dermatitis. Res Vet Sci 68:279-283.
  163. 149a. Meucci V, Vanni M, Guardabassi L, et al. 2010. Evaluation of methicillin resistance in Staphylococcus intermedius isolated from dogs. Vet Res Commun 34:S79-S82.
  164. Mertz P, Cardenas T, Snyder R, et al. 2007. Staphylococcus aureus virulence factors associated with infected skin lesions: influence on the local immune response. Arch Dermatol 143:1259-1263.
  165. 150a. Miedzobrodzki J, Kasprowicz A, Bialecka A, et al. 2010. The first case of Staphylococcus pseudintermedius infection after joint prosthesis implantation in a dog. Pol J Microbiol 59:133-135.
  166. Moodley A, Nightingale EC, Stegger M, et al. 2008. High risk for nasal carriage of methicillin-resistant Staphylococcus aureus among Danish veterinary practitioners. Scand J Work Env Health 34:151-157.
  167. Moodley A, Stegger M, Bagcigil A, et al. 2006. Spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland. J Antimicrob Chemother 58:1118-1123.
  168. Morales CA, Schultz, DeBoer DJ. 1994. Antistaphylococcal antibodies in dogs with recurrent staphylococcal pyoderma. Vet Immunol Immunopathol 42:137-147.
  169. Moreillon P, Que Y, Glauser MP. 2005. Staphylococcus aureus, including staphylococcal toxic shock, pp 2321-2351. In Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases, ed 6. Elsevier, Philadelphia.
  170. Morris D, Mauldin E, O'Shea K, et al. 2006. Clinical, microbiological, and molecular characterization of methicillin-resistant Staphylococcus aureus infections of cats. Am J Vet Res 67:1421-1425.
  171. Morris D, Rook K, Shofer F, et al. 2006. Screening of Staphylococcus aureus, Staphylococcus intermedius, and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04). Vet Dermatol 17:332-337.
  172. Morris MC, Donoghue A, Markowitz JA, et al. 2003. Ingestion of tea tree oil (Melaleuca oil) by a 4-year-old boy. Pediatr Emerg Care 19:169-171.
  173. Much P, Pichler J, Kasper SS, et al. 2009. Foodborne outbreaks, Austria 2007. Wien Klin Wochenschr 121:77-85.
  174. Mueller RS, Bettenay SV, Lording P, et al. 1998. Antibiotic sensitivity of Staphylococcus intermedius isolated from canine pyoderma. Aust Vet Pract 28:10-13.
  175. 159a. Murayama N, Nagata M, Terada Y, et al. 2010. Efficacy of a surgical scrub including 2% chlorhexidine acetate for canine superficial pyoderma. Vet Derm 21:586-592.
  176. 159b. Murphy CP, Reid-Smith RJ, Boerlin P, et al. 2010. Escherichia coli and selected veterinary and zoonotic pathogens isolated from environmental sites in companion animal veterinary hospitals in southern Ontario. Can Vet J 51:963-972.
  177. Nicolau DP, Tessier PR, Nightingale CH. 1999. Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents 11:159-161.
  178. Noble WC. 1993. Staphylococci on the skin, pp 135-152. In Noble WC (ed): The skin microflora and microbial skin disease. Cambridge University Press, Cambridge, UK.
  179. Noble WC, Kent LE. 1993. Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog. Vet Dermatol 3:71-74.
  180. Oluoch AO, Weisiger R, Siegel AM, et al. 1996. Trends of bacterial infections in dogs. Characterization of Staphylococcus intermedius isolates (1990-1992). Canine Pract 21:12-19.
  181. O’Mahony R, Abbott Y, Leonard F, et al. 2005. Methicillin-resistant Staphylococcus aureus (MRSA) isolated from animals and veterinary personnel in Ireland. Vet Microbiol 109:285-296.
  182. Oughton MT, Dick HLN, Willey BM, et al. 2001. Methicillin resistant Staphylococcus aureus (MRSA) as a cause of infections in domestic animals: evidence for a new humanotic disease? Presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy.
  183. Overturf GD, Talan DA, Singer K, et al. 1991. Phage typing of Staphylococcus intermedius. J Clin Microbiol 29:373-375.
  184. Owen MR, Moores AP, Coe RJ. 2004. Management of MRSA septic arthritis in a dog using a gentamicin-impregnated collagen sponge. J Small Anim Pract 45:609-612.
  185. Ozaki K, Yamagami T, Nomura K, et al. 2003. Abscess-forming inflammatory granulation tissue with gram-positive cocci and prominent eosinophil infiltration in cats: possible infection of methicillin-resistant Staphylococcus. Vet Pathol 40:283-287.
  186. Pak SI, Han HR, Shimizu A. 1999. Characterization of methicillin-resistant Staphylococcus aureus isolated from dogs in Korea. J Vet Med Sci 61:1013-1018.
  187. Papich MG. 2010. Proposed changes to clinical laboratory standards institute interpretive criteria for methicillin-resistant Staphylococcus pseudintermedius isolated from dogs. J Vet Diagn Invest 22:160.
  188. Papich MG. 2010. Thoughts on testing methods for bacterial isolates. J Am Vet Med Assoc 236:162.
  189. Paradis M, Abbey L, Baker B, et al. 2001. Evaluation of the clinical efficacy of marbofloxacin (Zeniquin) tablets for the treatment of canine pyoderma: an open clinical trial. Vet Dermatol 12:163-169.
  190. Paradis M, Lemay S, Scott DW, et al. 1990. Efficacy of enrofloxacin in the treatment of canine bacterial pyoderma. Vet Dermatol 1:123-127.
  191. Patel A, Lloyd DH, Howell SA, et al. 2002. Investigation into the potential pathogenicity of Staphylococcus felis in a cat. Vet Rec 150:668-669.
  192. Patel A, Lloyd DH, Lamport AI. 1999. Antimicrobial resistance of feline staphylococci in southeastern England. Vet Dermatol 10:257-261.
  193. Patel A, Lloyd DH, Lamport AI. 2000. The prevalence of feline staphylococci with special reference to Staphylococcus felis amongst domestic and feral cats in south-east of England. Vet Dermatol 11(Suppl 1):6-7.
  194. Patel A, Lloyd DH, Lamport AI 2002. Prevalence of feline staphylococci with special reference to Staphylococcus felis among domestic and feral cats in the south-east of England, pp 85-91. In Thody KL, Foil CS, Bond R (eds): Advances in veterinary dermatology, vol 4. Blackwell Science, Oxford.
  195. Pedersen K, Pedersen K, Jensen H, et al. 2007. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs. J Antimicrob Chemother 60:775-781.
  196. Pedersen K, Wegener HC. 1995. Antimicrobial susceptibility and rRNA gene restriction patterns among Staphylococcus intermedius from healthy dogs and from dogs suffering from pyoderma or otitis. Acta Vet Scand 36:335-342.
  197. Pellerin JL, Bourdeau P, Sebbag H, et al. 1998. Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas. Comp Immunol Microbiol Infect Dis 21:115-133.
  198. 180a. Penna B, Varges R, Martins R, et al. 2010. In vitro antimicrobial resistance of staphylococci isolated from canine urinary tract infection. Can Vet J 51:738-742.
  199. 180b. Penna B, Varges R, Medeiros L, et al. 2010. Species distribution and antimicrobial susceptibility of staphylococci isolated from canine otitis externa. Vet Derm 21:292-296.
  200. 180c. Perreten V, Kadelec K, Schwarz S, et al. 2010. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother 65:1145-1154.
  201. Petersen AD, Walker RD, Bowman MM, et al. 2002. Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). J Am Anim Hosp Assoc 38:407-413.
  202. Peterson PB, Miller MW, Hansen EK, et al. 2003. Septic pericarditis, aortic endarteritis, and osteomyelitis in a dog. J Am Anim Hosp Assoc 39:528-532.
  203. 182a. Pomba C, Couto N, Moodley A. 2010. Treatment of a lower urinary tract infection in a cat caused by a multi-drug methicillin-resistant Staphylococcus pseudintermedius and an Enterococcus faecalis. J Fel Med Surg 12:802-806.
  204. Prescott JF, Hanna WJB, Reid-Smith R, et al. 2002. Antimicrobial drug use and resistance in dogs. Can Vet J 43:107-116.
  205. Prevost G, Bouakham T, Piemont Y, et al. 1995. Characterisation of a synergohymenotropic toxin produced by Staphylococcus intermedius. FEBS Lett 376:135-140.
  206. Radaelli ST, Platt SR. 2002. Bacterial meningoencephalomyelitis in dogs: a retrospective study of 23 cases (1990-1999). J Vet Intern Med 16:159-163.
  207. Rahal SC, Mamprim MJ, Caporali EH, et al. 2003. Osteomyelitis associated with an orthopedic implant. Can Vet J 44:597, 599.
  208. Rankin S, Roberts S, O'Shea K, et al. 2005. Panton valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals. Vet Microbiol 108:145-148.
  209. Rantala M, Lahti E, Kuhalampil J, et al. 2004. Antimicrobial resistance in Staphylococcus spp. Escherichia coli and Enterococcus spp. in dogs given antibiotics for chronic dermatological disorders, compared with non-treated dogs. Acta Vet Scand 45:37-40.
  210. Reiman KA, Evans MG, Chalifoux LV, et al. 1989. Clinicopathologic characterization of canine juvenile cellulites. Vet Pathol 26:499-504.
  211. Rich M, Deighton L, Roberts L. 2005. Clindamycin-resistance in methicillin-resistant Staphylococcus aureus isolated from animals. Vet Microbiol 111:237-240.
  212. Rich M, Roberts L, Jones M, et al. 2007. Staphylococcus schleiferi subspecies coagulans in companion animals. Vet Rec 161:107.
  213. Ross-Fitzgerald J. 2009. The Staphylococcus intermedius group of bacterial pathogens: species reclassification, pathogenesis and the emergence of meticillin resistance. Vet Dermatol 20:490-495.
  214. 192a. Rubin JE, Chirino-Trejo M. 2010. Pharyngeal, rectal and nasal colonization of clinically healthy dogs with staphylococcus aureus. Vet Microbiol 143:440-441.
  215. Ruscher C, Lübke-Becker A, Wleklinski CG, et al. 2008. Prevalence of methicillin-resistant Staphylococcus pseudintermedius isolated from clinical samples of companion animals and equidaes. Vet Microbiol 136:197-201.
  216. Saijonmaa-Koulumies L, Parsons E, Lloyd DH. 1998. Elimination of Staphylococcus intermedius in healthy dogs by topical treatment with fusidic acid. J Small Anim Pract 39:341-347.
  217. Saijonmaa-Koulumies LE, Lloyd DH. 1995. Carriage of bacteria antagonistic towards Staphylococcus intermedius on canine skin and mucosal surfaces. Vet Dermatol 6:187-194.
  218. Saijonmaa-Koulumies LE, Lloyd DH. 1996. Colonization of the canine skin with bacteria. Vet Dermatol 7:153-162.
  219. Saijonmaa-Koulumies LE, Lloyd DH. 2002. Adherence of Staphylococcus intermedius to canine corneocytes in vitro. Vet Dermatol 13:169-176.
  220. Saijonmaa-Koulumies LE, Lloyd DH 2002. Colonization of neonatal puppies by Staphylococcus intermedius. Vet Dermatol 13:123-130.
  221. Saijonmaa-Koulumies LE, Myllys V, Lloyd DH. 2003. Diversity and stability of the Staphylococcus intermedius flora in three bitches and their puppies. Epidemiol Infect 131:931-937.
  222. Sasaki T, Kikuchi K, Tanaka Y, et al. 2007. Methicillin-resistant Staphylococcus pseudintermedius in a veterinary teaching hospital. J Clin Microbiol 45:1118-1125.
  223. Sasaki T, Kikuchi K, Tanaka Y, et al. 2007. Reclassification of phenotypically-identified Staphylococcus intermedius strains. J Clin Microbiol 45:2770-2778.
  224. Schäfer-Somi S, Spergser J, Breitenfellner J, et al. 2003. Bacteriological status of canine milk and septicaemia in neonatal puppies—a retrospective study. J Vet Med B Infect Dis Vet Public Health 50:343-346.
  225. Schenfeld LA. 2000. Images in clinical medicine. Staphylococcal scalded skin syndrome. N Engl J Med 342:1178.
  226. Schocken-Iturrino RP, Carneiro MC, Kato E, et al. 1999. Study of the presence of the spores of Clostridium botulinum in honey in Brazil. FEMS Immunol Med Microbiol 24:379-382.
  227. 204a. Schwartz M, Boettcher IC, Kramer S, et al. 2009. Two dogs with iatrogenic discospondylitis caused by meticillin-resistant Staphylococcus aureus. J Sm Anim Pract 50:201-205.
  228. Schwartz S, Noble WC. 1999. Aspects of bacterial resistance to antimicrobials used in veterinary dermatological practice. Vet Dermatol 10:163-176.
  229. Schwarz S, Roberts MC, Werckenthin C, et al. 1998. Tetracycline resistance in Staphylococcus spp. from domestic animals. Vet Microbiol 63:217-227.
  230. Schwartz S, Werckenthin C, Pinter L, et al. 1995. Chloramphenicol resistance in Staphylococcus intermedius from a single veterinary centre: evidence for plasmid and chromosomal location of the resistance genes. Vet Microbiol 43:151-159.
  231. 207a. Scott B, Mortensen J, McKeever T, et al. 2010. Efficacy of tylosin tartrate on canine Staphylococcus intermedius isolates in vitro. Vet Ther 11:E1-E7.
  232. Scott DW, Miller WH, Cayatte SM, et al. 1994. Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs. Can Vet J 35:617-621.
  233. Scott DW, Peters J, Miller WH. 2006. Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs. Can Vet J 47:999-1002.
  234. Seguin JC, Walker RD, Caron JP, et al. 1999. Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: potential human-to-animal transmission. J Clin Microbiol 37:1459-1463.
  235. Share B, Utroska B. 2002. Intra-abdominal botryomycosis in a dog. J Am Vet Med Assoc 220:1025-1027.
  236. Shaw SE. 2004. Dogs, cats and methicillin-resistant Staphylococcus aureus. J Small Anim Pract 45:587-588.
  237. Shearer DH, Day MJ. 1997. Aspects of the humoral immune response to Staphylococcus intermedius in dogs with superficial pyoderma, deep pyoderma, and anal furunculosis. Vet Immunol Immunopathol 58:107-120.
  238. Shimizu A, Berkhoff HA, Kloos WE, et al. 1996. Genomic DNA finger-printing using pulsed-field gel electrophoresis of Staphylococcus intermedius isolated from dogs. Am J Vet Res 57:1458-1462.
  239. Shimizu A, Wakita Y, Nagase S, et al. 2001. Antimicrobial susceptibility of Staphylococcus intermedius isolated from healthy and diseased dogs. J. Vet Med Sci. 63:357-360.
  240. Simoons-Smit AM, Savelkoul PH, Stoof J, et al. 2000. Transmission of Staphylococcus aureus between humans and domestic animals in a household. Eur J Clin Microbiol Infect Dis 19:150-152.
  241. Sing A, Tuschak C, Hörmansdorfer S. 2008. Methicillin-resistant Staphylococcus aureus in a family and its pet cat. N Engl J Med 358:1200-1201.
  242. Smith AN, Finn-Bodner ST, Dillon AR. 2000. Left ventricular outflow tract to left atrial fistula associated with endocarditis in a dog. J Am Anim Hosp Assoc 36:133-136.
  243. Söderberg TA, Johansson A, Gref R. 1996. Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells. Toxicology 107:99-109.
  244. 219a. Stegmann R, Burnens A, Maranta CA, et al. 2010. Human infection associated with methicillin-resistant Staphylococcus pseudintermedius ST71. J Antimicrob Chemother 65:2047-2048.
  245. Stepanovic S, Dimitrijevic V, Vukovic D. 2001. Staphylococcus sciuri as a part of skin, nasal and oral flora in healthy dogs. Vet Microbiol 82:177-185.
  246. Talan DA, Staatz D, Staatz A, et al. 1989. Frequency of Staphylococcus intermedius as human nasopharyngeal flora. J Clin Microbiol 27:2393.
  247. Talan DA, Staatz D, Staatz A, et al. 1989. Staphylococcus intermedius in canine gingival and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol 27:78-81.
  248. Tanner MA, Everett CL, Youvan DC. 2000. Molecular phylogenetic evidence for noninvasive zoonotic transmission of Staphylococcus intermedius from a canine pet to a human. J Clin Microbiol 38:1628-1631.
  249. Tejedor Junco MT, Martín Barrasa JL. 2002. Identification and antimicrobial susceptibility of coagulase positive staphylococci isolated from healthy dogs and dogs suffering from otitis externa. J Vet Med B Infect Dis Vet Public Health 49:419-423.
  250. Terauchi R, Sato H, Hasegawa T, et al. 2003. Isolation of exfoliative toxin from Staphylococcus intermedius and its local toxicity in dogs. Vet Microbiol 94:19-29.
  251. Thamm DH, Kurzman ID, Macewen EG, et al. 2003. Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors. Cancer Immunol Immunother 52:473-480.
  252. Thompson LA, Grieshaber TL, Glickman L, et al. 2004. Human recombinant interferon alpha-2b for management of idiopathic recurrent superficial pyoderma in dogs, a pilot study. Vet Ther 5:75-81.
  253. Tomlin J, Pead MJ, Lloyd DH, et al. 1999. Methicillin-resistant Staphylococcus aureus infections in eleven dogs. Vet Rec 144:60-64.
  254. Trolldenier H, Wagner J. 2001. Minimal inhibitory concentrations of commonly used antibiotics for treatment of common veterinary pathogens—a multicenter study in Germany. Part II: Staphylococcus aureus and Staphylococcus intermedius strains. Praktische Tierarzt 82:118-129.
  255. Ulkür E, Oncul O, Karagoz H, et al. 2005. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant staphylococci-contaminated, full-skin thickness rat burn wounds. Burns 31:874-877.
  256. Valentine BA, Dew W, Yu A, et al. 2009. Evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius. ASM-ESCMID conference on methicillin-resistant staphylococci in animals, London, Sept 22–25. A-127.
  257. Vandenesch F, Célard M, Arpin D, et al. 1995. Catheter-related bacteremia associated with coagulase-positive Staphylococcus intermedius. J Clin Microbiol 33:2508-2510.
  258. van Duijkeren E, Box AT, Heck MC, et al. 2004. Methicillin-resistant staphylococci isolated from animals. Vet Microbiol 103:91-97.
  259. van Duijkeren E, Box AT, Mulder J, et al. 2003. [Methicillin resistant Staphylococcus aureus (MRSA) infection in a dog in the Netherlands]. Tijdschr Diergeneeskd 128:314-315.
  260. van Duijkeren E, Houwers DJ, Schoormans A, et al. 2008. Transmission of methicillin-resistant Staphylococcus intermedius between humans and animals. Vet Microbiol 128:213-215.
  261. van Duijkeren E, Wolfhagen MS, Box AT, et al. 2004. Human-to-dog transmission of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 10:2235-2237.
  262. van Duijkeren E, Wolfhagen MJ, Heck ME, et al. 2005. Transmission of a Panton-Valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. J Clin Microbiol 43:6209-6211.
  263. Vanni M, Tognetti R, Pretti C, et al. 2009. Antimicrobial susceptibility of Staphylococcus intermedius and Staphylococcus schleiferi isolated from dogs. Res Vet Sci 87:192-195.
  264. Vengust M, Anderson M, Rousseau J, et al. 2006. Methicillin-resistant staphylococcal colonization in clinically normal dogs and horses in the community. Lett Appl Microbiol 43:602-606.
  265. 239a. Vincze S, Paasch A, Walther B, et al. 2010. Multidrug- and methicillin resistant Staphylococcus pseudintermedius as a cause of canine pyoderma: a case report. Berl Munch Tierarztl 123:353-358.
  266. Vitale C, Gross T, Weese J. 2006. Methicillin-resistant Staphylococcus aureus in cat and owner. Emerg Infect Dis 12:1998-2000.
  267. Voyich J, Otto M, Mathema B, et al. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194:1761-1770.
  268. Wakita Y, Shimizu A, Hajek V, et al. 2002. Characterization of Staphylococcus intermedius from pigeons, dogs, foxes, mink, and horses by pulsed-field gel electrophoresis. J Vet Med Sci 64:237-243.
  269. Weese J, Dick H, Willey B, et al. 2006. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol 115:148-155.
  270. Weese S, Poma R, James F, et al. 2009. Staphylococcus pseudintermedius necrotizing fasciitis in a dog. Can Vet J 50:655-656.
  271. Weese J, Rousseau J, Willey B, et al. 2006. Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med 20:182-186.
  272. Weese JS. 2008. Issues regarding the use of vancomycin in companion animals. J Am Vet Med Assoc 233:565-567.
  273. Weese JS, Faires M, Brisson BA, et al. 2009. Infection with methicillin-resistant Staphylococcus pseudintermedius masquerading as cefoxitin susceptible in a dog. J Am Vet Med Assoc 235:1064-1066.
  274. Weese JS, Faires M, Rousseau J, et al. 2007. Cluster of methicillin-resistant Staphylococcus aureus colonization in a small animal intensive care unit. J Am Vet Med Assoc 231:1361-1364.
  275. Weese JS, Frank LA, Reynolds LM, et al. 2009. Retrospective study of methicillin-resistant and methicillin-susceptible Staphylococcus pseudintermedius infections in dogs. ASM-ESCMID conference on methicillin-resistant staphylococci in animals 2009; A-67.
  276. Weese JS, van Duijkeren E. 2010. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol 140:418-429.
  277. Wegener HC, Pedersen K. 1992. Variations in antibiograms and plasmid profiles among multiple isolates of Staphylococcus intermedius from pyoderma in dogs. Acta Vet Scand 33:391-394.
  278. Werner AH. 2003. Psoriasiform-lichenoid-like dermatosis in three dogs treated with microemulsified cyclosporine A. J Am Vet Med Assoc 223:1013-1016.
  279. Wissing A, Nicolet J, Boerlin P. 2001. The current antimicrobial resistance situation in Swiss veterinary medicine. Schweiz Arch Tierheilkunde 143:503-510.
  280. Woldehiwet Z, Jones JJ. 1990. Species distribution of coagulase-positive staphylococci isolated from dogs. Vet Rec 126:485.
  281. Wulf M, van Nes A, Eikelenboom-Boskamp A, et al. 2006. Methicillin-resistant Staphylococcus aureus in veterinary doctors and students, the Netherlands. Emerg Infect Dis 12:1939-1941.
  282. 255a. Yoo JH, Yoon JW, Lee SY, et al. 2010. High prevalence of fluoroquinolone- and methicillin-resistant Staphylococcus pseudintermedius from canine pyoderma and otitis externa in veterinary teaching hospital. J Microbiol Biotechnol 20:798-802.
  283. 255b. Youn JH, Hwang SY, Kim SH, et al. 2010. mecA gene transferrabilitgy and antibiogram of zoonotic Staphylococcus intermedius from animals, staff and the environment in animal hospitals in Korea. J Microbiol Biotechnol 20:425-432.
  284. Zdovc I, Ocepek M, Pirs T, et al. 2004. Microbiologic features of Staphylococcus schleiferi subsp coagulans isolated from dogs and possible misidentification with other canine coagulase positive staphylococci. J Vet Med B Infect Dis Vet Public Health 51:449-454.
  285. Zubeir I, Kanbar T, Alber J, et al. 2007. Phenotypic and genotypic characteristics of methicillin/oxacillin-resistant Staphylococcus intermedius isolated from clinical specimens during routine veterinary microbiological examinations. Vet Microbiol 121:170-176.